InsightfulValue
โ† Home

Pfizer
Pfizer

-12.34%

Pharma / Pharmaceuticals and biotechnology


๐Ÿ”ง Tools

โœ… Due Diligence
Company at a Glance

Pfizer

๐Ÿ“Š Get full analytics about Pfizer

Sign up for free or log in

โœ๏ธ Sign up to get "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks" for free

Price
Live  
Infographic
Infographics
Overview
Pfizer, Inc. is a multinational pharmaceutical company founded in 1849 by Charles Pfizer and Charles Erhart in Brooklyn, New York. The company is currently headquartered in New York City and operates in over 175 countries around the world.
Pfizer is known for its innovations in medicine, and has developed multiple blockbuster drugs, including Viagra, Lipitor, and Celebrex. The company has a diverse portfolio of prescription medicines, vaccines, and consumer healthcare products.
Pfizer works to improve global health by providing access to quality healthcare, increasing access to medicines, and investing in medical research and development. The company also partners with organizations and governments to address public health challenges, such as addressing infectious diseases and expanding access to healthcare in emerging markets.
In addition to its focus on healthcare and pharmaceuticals, Pfizer has a strong commitment to corporate responsibility and sustainability. The company aims to reduce its environmental impact, promote diversity and inclusion, and support community outreach initiatives.
Overall, Pfizer's mission is to discover, develop, and provide innovative medicines and vaccines that improve the lives of people around the world.
How to explain to a 10 year old kid about the company?
Pfizer

๐Ÿ“ˆ Want to read more about Pfizer?

Sign up for free or log in

๐Ÿ’ก Learn smarter stock picks with "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks"

UGZpemVyIG lzIGEgYmln IGNvbXBhbn kgdGhhdCBt YWtlcyBtZW RpY2luZXMg YW5kIHZhY2 NpbmVzIHRv IGhlbHAgcG VvcGxlIGZl ZWwgYmV0dG VyIGFuZCBz dGF5IGhlYW x0aHkuIFRo aW5rIG9mIH RoZW0gbGlr ZSBhIHN1cG VyaGVybyBm b3Igb3VyIG hlYWx0aC4g V2hlbiBwZW 9wbGUgZ2V0 IHNpY2sgb3 IgbmVlZCBt ZWRpY2luZS B0byBwcmV2 ZW50IGdldH Rpbmcgc2lj aywgZG9jdG 9ycyBvZnRl biB1c2UgdG hpbmdzIHRo YXQgUGZpem VyIGhhcyBj cmVhdGVkLj xicj5Tbywg aG93IGRvZX MgUGZpemVy IG1ha2UgbW 9uZXk/IFdo ZW4gZG9jdG 9ycyBnaXZl IHRoZWlyIH BhdGllbnRz IHRoZXNlIG 1lZGljaW5l cyBhbmQgdm FjY2luZXMs IGhvc3BpdG FscyBhbmQg cGhhcm1hY2 llcyBidXkg dGhlbSBmcm 9tIFBmaXpl ci4gVGhlIG NvbXBhbmll cyB0aGVuIH NlbGwgdGhv c2UgbWVkaW NpbmVzIHRv IHBlb3BsZS wgYW5kIHRo YXTigJlzIG hvdyBQZml6 ZXIgZWFybn MgbW9uZXku IFRoZXkgYW xzbyBnZXQg bW9uZXkgd2 hlbiB0aGV5 IGNyZWF0ZS BuZXcgbWVk aWNpbmVzIG FuZCBzZWxs IHRoZW0gdG 8gb3RoZXIg Y291bnRyaW VzIGFyb3Vu ZCB0aGUgd2 9ybGQuPGJy PlBmaXplci BpcyBzdWNj ZXNzZnVsIG ZvciBhIGZl dyByZWFzb2 5zLiBGaXJz dCwgdGhleS BzcGVuZCBh IGxvdCBvZi B0aW1lIGFu ZCBtb25leS BtYWtpbmcg c3VyZSB0aG VpciBtZWRp Y2luZXMgYX JlIGJvdGgg c2FmZSBhbm QgZWZmZWN0 aXZlIGJlZm 9yZSB0aGV5 IGNhbiBzZW xsIHRoZW0u IFRoaXMgZ2 l2ZXMgcGVv cGxlIGFuZC Bkb2N0b3Jz IGNvbmZpZG VuY2UgaW4g dGhlaXIgcH JvZHVjdHMu IFNlY29uZC wgUGZpemVy IGlzIGFsd2 F5cyB3b3Jr aW5nIG9uIG 5ldyBtZWRp Y2luZXMgYW 5kIHZhY2Np bmVzLCB3aG ljaCBtZWFu cyB0aGV5IG FyZSBhbHdh eXMgbG9va2 luZyBmb3Ig d2F5cyB0by BoZWxwIGV2 ZW4gbW9yZS BwZW9wbGUu IEZvciBleG FtcGxlLCB0 aGV5IGhlbH BlZCBtYWtl IGEgQ09WSU QtMTkgdmFj Y2luZSB0aG F0IG1hbnkg cGVvcGxlIG dvdCB0byBw cm90ZWN0IH RoZW1zZWx2 ZXMgZnJvbS B0aGUgdmly dXMuPGJyPk luIHRoZSBm dXR1cmUsIF BmaXplciB3 aWxsIGxpa2 VseSBjb250 aW51ZSB0by BiZSBzdWNj ZXNzZnVsIG JlY2F1c2Ug dGhlcmUgd2 lsbCBhbHdh eXMgYmUgYS BuZWVkIGZv ciBuZXcgbW VkaWNpbmVz IGFuZCB2YW NjaW5lcy4g UGVvcGxlIH dpbGwgYWx3 YXlzIGdldC BzaWNrIGFu ZCBuZWVkIG hlbHAsIGFu ZCBzY2llbn Rpc3RzIGFy ZSBhbHdheX MgZGlzY292 ZXJpbmcgbm V3IHRoaW5n cyBhYm91dC BoZWFsdGgs IHdoaWNoIG 1lYW5zIG1v cmUgb3Bwb3 J0dW5pdGll cyBmb3IgUG ZpemVyIHRv IGhlbHAuIF RoZXkgaGF2 ZSBhIGdvb2 QgdGVhbSBv ZiBzY2llbn Rpc3RzIGFu ZCByZXNlYX JjaGVycyB3 aG8ga2VlcC BjcmVhdGlu ZyBtb3JlIH dheXMgdG8g aGVscCBwZW 9wbGUsIHdo aWNoIGlzIH doeSB0aGV5 IHdpbGwgcH JvYmFibHkg a2VlcCBiZW luZyBzdWNj ZXNzZnVsIG ZvciBtYW55 IHllYXJzIH RvIGNvbWUu PGJyPg==
What is special about the company?
Pfizer

๐Ÿ“ˆ Want to read more about Pfizer?

Sign up for free or log in

๐Ÿ“˜ Claim your free eBook: "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks"

MS4gUGlvbm VlciBpbiB0 aGUgcGhhcm 1hY2V1dGlj YWwgaW5kdX N0cnk6IFBm aXplciBpcy BvbmUgb2Yg dGhlIHdvcm xkJ3Mgb2xk ZXN0IGFuZC BsYXJnZXN0 IHBoYXJtYW NldXRpY2Fs IGNvbXBhbm llcywgZXN0 YWJsaXNoZW QgaW4gMTg0 OS4gSXQgaG FzIGEgbG9u ZyBoaXN0b3 J5IG9mIGRl dmVsb3Bpbm cgYW5kIG1h bnVmYWN0dX JpbmcgaW5u b3ZhdGl2ZS BtZWRpY2lu ZXMsIG1ha2 luZyBpdCBh IHRydXN0ZW QgYnJhbmQg aW4gdGhlIG dsb2JhbCBo ZWFsdGhjYX JlIGluZHVz dHJ5Ljxicj 4yLiBTdHJv bmcgcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50OiBQ Zml6ZXIgaG FzIGEgcm9i dXN0IHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBw cm9ncmFtLC BpbnZlc3Rp bmcgYmlsbG lvbnMgb2Yg ZG9sbGFycy Bhbm51YWxs eSBpbiB0aG UgZGV2ZWxv cG1lbnQgb2 YgbmV3IG1l ZGljaW5lcy BhbmQgdHJl YXRtZW50cy 4gSXRzIHRl YW0gb2Ygc2 NpZW50aXN0 cywgcmVzZW FyY2hlcnMs IGFuZCBjbG luaWNpYW5z IHdvcmsgdG 9nZXRoZXIg dG8gc29sdm Ugc29tZSBv ZiB0aGUgbW 9zdCBzaWdu aWZpY2FudC BoZWFsdGhj YXJlIGNoYW xsZW5nZXMg YW5kIGltcH JvdmUgcGF0 aWVudCBvdX Rjb21lcy48 YnI+My4gR2 xvYmFsIHBy ZXNlbmNlOi BQZml6ZXIg aGFzIGEgc3 Ryb25nIGds b2JhbCBwcm VzZW5jZSwg d2l0aCBvcG VyYXRpb25z IGluIG92ZX IgMTc1IGNv dW50cmllcy BhbmQgdGVy cml0b3JpZX Mgd29ybGR3 aWRlLiBJdC BoYXMgYSBk aXZlcnNpZm llZCBwb3J0 Zm9saW8gb2 YgcHJvZHVj dHMgYW5kIH NlcnZlcyBh IGJyb2FkIH JhbmdlIG9m IHRoZXJhcG V1dGljIGFy ZWFzLCBpbm NsdWRpbmcg aW5mZWN0aW 91cyBkaXNl YXNlcywgb2 5jb2xvZ3ks IHJhcmUgZG lzZWFzZXMs IGFuZCBjYX JkaW92YXNj dWxhciBkaX NvcmRlcnMu PGJyPjQuIE ZvY3VzIG9u IGlubm92YX Rpb246IFdp dGggYSBkZW RpY2F0ZWQg YW5kIGhpZ2 hseSBza2ls bGVkIHRlYW 0gb2Ygc2Np ZW50aXN0cy BhbmQgcmVz ZWFyY2hlcn MsIFBmaXpl ciBjb250aW 51ZXMgdG8g aW5ub3ZhdG UgYW5kIGRl dmVsb3Agbm V3IHRyZWF0 bWVudHMgZm 9yIHVubWV0 IG1lZGljYW wgbmVlZHMu IEl0IGhvbG RzIG51bWVy b3VzIHBhdG VudHMgYW5k IGhhcyBzZX ZlcmFsIHN1 Y2Nlc3NmdW wgcHJvZHVj dHMsIHN1Y2 ggYXMgVmlh Z3JhLCBMaX BpdG9yLCBh bmQgUHJldm 5hci48YnI+ NS4gQ29tbW l0bWVudCB0 byBxdWFsaX R5IGFuZCBz YWZldHk6IF BmaXplciBo YXMgYSBzdH JpY3QgcXVh bGl0eSBjb2 50cm9sIHN5 c3RlbSBpbi BwbGFjZSB0 byBlbnN1cm UgdGhlIHNh ZmV0eSBhbm QgZWZmaWNh Y3kgb2YgaX RzIHByb2R1 Y3RzLiBJdC Bmb2xsb3dz IHN0cmljdC BtYW51ZmFj dHVyaW5nIH N0YW5kYXJk cyBhbmQgcm VndWxhdGlv bnMgaW4gYW xsIGl0cyBm YWNpbGl0aW VzIHdvcmxk d2lkZSB0by BkZWxpdmVy IHNhZmUgYW 5kIGVmZmVj dGl2ZSBtZW RpY2luZXMg dG8gcGF0aW VudHMuPGJy PjYuIFNvY2 lhbCByZXNw b25zaWJpbG l0eTogUGZp emVyIGlzIG NvbW1pdHRl ZCB0byBtYW tpbmcgYSBw b3NpdGl2ZS BpbXBhY3Qg b24gdGhlIG NvbW11bml0 aWVzIGl0IH NlcnZlcy4g VGhyb3VnaC BpdHMgY29y cG9yYXRlIH NvY2lhbCBy ZXNwb25zaW JpbGl0eSBp bml0aWF0aX ZlcywgdGhl IGNvbXBhbn kgc3VwcG9y dHMgdmFyaW 91cyBoZWFs dGhjYXJlIH Byb2dyYW1z LCBlZHVjYX Rpb24sIGFu ZCBlbnZpcm 9ubWVudGFs IHN1c3RhaW 5hYmlsaXR5 IGVmZm9ydH MuPGJyPjcu IFN0cm9uZy BmaW5hbmNp YWwgcGVyZm 9ybWFuY2U6 IFBmaXplci BpcyBhIGZp bmFuY2lhbG x5IHN0YWJs ZSBjb21wYW 55IHdpdGgg YSBzdHJvbm cgdHJhY2sg cmVjb3JkIG 9mIGdyb3d0 aCBhbmQgcH JvZml0YWJp bGl0eS4gSX RzIGZpbmFu Y2lhbCBzdG FiaWxpdHkg YW5kIHBlcm Zvcm1hbmNl IGFyZSByZW ZsZWN0ZWQg aW4gY29uc2 lzdGVudGx5 IGhpZ2ggc3 RvY2sgcHJp Y2VzIGFuZC BjcmVkaXQg cmF0aW5ncy 48YnI+OC4g SW5ub3ZhdG l2ZSBwYXJ0 bmVyc2hpcH M6IFBmaXpl ciBoYXMgcG FydG5lcmVk IHdpdGggb3 RoZXIgbGVh ZGluZyBwaG FybWFjZXV0 aWNhbCBjb2 1wYW5pZXMs IGFjYWRlbW ljIGluc3Rp dHV0aW9ucy wgYW5kIGdv dmVybm1lbn QgYWdlbmNp ZXMgdG8gYW NjZWxlcmF0 ZSBpbm5vdm F0aW9uIGFu ZCBicmluZy BuZXcgdHJl YXRtZW50cy B0byBtYXJr ZXQuIFRoZX NlIGNvbGxh Ym9yYXRpb2 5zIGVuaGFu Y2UgdGhlIG NvbXBhbnkn cyByZXNlYX JjaCBjYXBh YmlsaXRpZX MgYW5kIGV4 cGFuZCBpdH MgcmVhY2gg aW4gdGhlIG dsb2JhbCBo ZWFsdGhjYX JlIG1hcmtl dC4=
What the company's business model?
Pfizer

๐Ÿ“ˆ Want to read more about Pfizer?

Sign up for free or log in

๐Ÿ“– Get insights from "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks" now!

UGZpemVyIG lzIGEgbXVs dGluYXRpb2 5hbCBwaGFy bWFjZXV0aW NhbCBjb21w YW55IHdpdG ggYSBidXNp bmVzcyBtb2 RlbCBiYXNl ZCBvbiByZX NlYXJjaCwg ZGV2ZWxvcG 1lbnQsIHBy b2R1Y3Rpb2 4sIGFuZCBt YXJrZXRpbm cgb2YgaW5u b3ZhdGl2ZS BhbmQgZ2Vu ZXJpYyBwcm VzY3JpcHRp b24gZHJ1Z3 MsIHZhY2Np bmVzLCBhbm QgY29uc3Vt ZXIgaGVhbH RoY2FyZSBw cm9kdWN0cy 4gSXRzIGJ1 c2luZXNzIG 9wZXJhdGlv bnMgYXJlIH NlZ21lbnRl ZCBpbnRvIH RocmVlIG1h aW4gYXJlYX M6IElubm92 YXRpdmUgSG VhbHRoLCBF c3NlbnRpYW wgSGVhbHRo LCBhbmQgQ2 9uc3VtZXIg SGVhbHRoY2 FyZS48YnI+ VGhlIElubm 92YXRpdmUg SGVhbHRoIH NlZ21lbnQg Zm9jdXNlcy BvbiBkZXZl bG9waW5nIG FuZCBjb21t ZXJjaWFsaX ppbmcgbmV3 IG1lZGljaW 5lcyBpbiBh cmVhcyBzdW NoIGFzIG9u Y29sb2d5LC BpbmZsYW1t YXRpb24gYW 5kIGltbXVu b2xvZ3ksIH JhcmUgZGlz ZWFzZXMsIG FuZCB2YWNj aW5lcy4gVG hpcyBpbmNs dWRlcyBpbn Zlc3Rpbmcg aW4gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IHRv IGRpc2Nvdm VyIG5ldyB0 cmVhdG1lbn RzLCBvYnRh aW5pbmcgcm VndWxhdG9y eSBhcHByb3 ZhbCwgYW5k IG1hcmtldG luZyBhbmQg c2VsbGluZy B0aGVtIHdv cmxkd2lkZS 48YnI+VGhl IEVzc2VudG lhbCBIZWFs dGggc2VnbW VudCBwcmlt YXJpbHkgZm 9jdXNlcyBv biB0aGUgcH JvZHVjdGlv biBhbmQgc2 FsZSBvZiBl c3RhYmxpc2 hlZCBnZW5l cmljIG1lZG ljaW5lcywg YXMgd2VsbC BhcyBiaW9z aW1pbGFycy 4gVGhlc2Ug YXJlIGxvd2 VyLWNvc3Qg YWx0ZXJuYX RpdmVzIHRv IGJyYW5kZW QgZHJ1Z3Mg YW5kIGFyZS BwcmltYXJp bHkgdXNlZC B0byB0cmVh dCBjb21tb2 4gY29uZGl0 aW9ucyBzdW NoIGFzIGh5 cGVydGVuc2 lvbiBhbmQg ZGlhYmV0ZX MuPGJyPlRo ZSBDb25zdW 1lciBIZWFs dGhjYXJlIH NlZ21lbnQg aW5jbHVkZX Mgb3Zlci10 aGUtY291bn RlciAoT1RD KSBwcm9kdW N0cyBzdWNo IGFzIG51dH JpdGlvbmFs IHN1cHBsZW 1lbnRzLCBw YWluIHJlbG lldmVycywg YW5kIHBlcn NvbmFsIGNh cmUgaXRlbX MuIFRoZXNl IHByb2R1Y3 RzIGFyZSBz b2xkIGRpcm VjdGx5IHRv IGNvbnN1bW VycyB3aXRo b3V0IGEgcH Jlc2NyaXB0 aW9uIGFuZC BhcmUgd2lk ZWx5IGF2YW lsYWJsZSBp biByZXRhaW wgc3RvcmVz Ljxicj5QZm l6ZXIncyBi dXNpbmVzcy Btb2RlbCBh bHNvIGluY2 x1ZGVzIHN0 cmF0ZWdpYy BwYXJ0bmVy c2hpcHMgYW 5kIGNvbGxh Ym9yYXRpb2 5zIHdpdGgg b3RoZXIgcG hhcm1hY2V1 dGljYWwgY2 9tcGFuaWVz LCBhY2FkZW 1pYyBpbnN0 aXR1dGlvbn MsIGFuZCBn b3Zlcm5tZW 50IG9yZ2Fu aXphdGlvbn MgdG8gZnVy dGhlciBlbm hhbmNlIHRo ZWlyIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBl ZmZvcnRzLj xicj5PdmVy YWxsLCBQZm l6ZXIncyBi dXNpbmVzcy Btb2RlbCBp cyBjZW50ZX JlZCBvbiBp bm5vdmF0aW 9uLCBtYXJr ZXQgZXhwYW 5zaW9uLCBh bmQgY29sbG Fib3JhdGlv biB0byBwcm 92aWRlIGEg ZGl2ZXJzZS Bwb3J0Zm9s aW8gb2YgcH JvZHVjdHMg dGhhdCBpbX Byb3ZlIHRo ZSBoZWFsdG ggYW5kIHdl bGwtYmVpbm cgb2YgcGVv cGxlIGFyb3 VuZCB0aGUg d29ybGQu
Is AI a threat?
AI does pose certain risks to Pfizerโ€™s products, services, and competitive positioning, although the extent of these threats may vary.
1. Substitution: AI-driven pharmaceutical technologies could lead to the development of alternative therapies or treatments that may circumvent traditional pharmaceutical approaches. For instance, AI can optimize drug discovery and development processes, potentially leading to faster and more cost-effective treatments that challenge Pfizerโ€™s existing product lines. Advances in biotechnology, including gene editing and personalized medicine facilitated by AI, could produce therapies that compete directly with Pfizerโ€™s offerings.
2. Disintermediation: AI has the potential to streamline healthcare delivery, which might reduce the need for intermediaries, such as healthcare providers or pharmaceutical sales representatives. For example, telemedicine platforms powered by AI could lower barriers to accessing medications, allowing patients to obtain treatments through direct-to-consumer models. This shift could disrupt Pfizerโ€™s traditional distribution channels and market strategies.
3. Margin Pressure: The increasing use of AI can lead to more efficient drug development processes, potentially lowering the cost of bringing new drugs to market. While this could result in lower prices for consumers, it may also put pressure on Pfizerโ€™s profit margins. If competitors leverage AI effectively to reduce costs, Pfizer might face challenges in maintaining pricing power for its products.
Overall, while AI presents opportunities for innovation and efficiency, it also introduces competitive pressures that could impact Pfizerโ€™s market positioning and profitability. The company would need to adapt by investing in AI technologies and developing strategies to mitigate these risks.
Sensitivity to interest rates
The sensitivity of Pfizerโ€™s earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Earnings Sensitivity: Changes in interest rates can affect Pfizerโ€™s earnings primarily through their impact on the cost of borrowing and investment decisions. If interest rates rise, the cost of financing existing debt may increase, potentially reducing net income. Additionally, higher rates could lead to decreased consumer spending and healthcare investment, which might lower demand for Pfizerโ€™s products, particularly in noessential categories.
2. Cash Flow Sensitivity: Pfizerโ€™s cash flow can also be sensitive to interest rate changes. Higher interest rates can result in increased interest expenses, which would decrease operating cash flow. Additionally, an environment of rising rates may slow down economic growth, potentially impacting sales and, subsequently, cash flows from operations. Conversely, if rates decrease, Pfizer might benefit from lower borrowing costs, enhancing cash flow.
3. Valuation Sensitivity: The valuation of Pfizer, often assessed through discounted cash flow (DCF) models, is significantly affected by interest rates. Higher interest rates increase the discount rate used to calculate the present value of future cash flows, typically resulting in a lower valuation. In contrast, lower rates would decrease the discount rate and could potentially enhance valuation. Moreover, shifts in interest rates can impact investor sentiment and risk perception, which can also influence stock price movements.
4. Market Conditions: The broader market can amplify Pfizerโ€™s sensitivity to interest rate changes. For instance, when rates rise, it might lead to a rotation out of growth stocks, affecting valuation multiples. Changes in interest rates may also influence regulatory and reimbursement environments, further affecting Pfizerโ€™s business dynamics.
In summary, Pfizerโ€™s earnings, cash flow, and valuation are notably sensitive to changes in interest rates due to their impact on borrowing costs, consumer demand, and overall economic conditions. Each increase or decrease in rates can have downstream effects that may influence the companyโ€™s financial health and market perception.
Resilience to the future changes
Pfizer

๐Ÿ“ˆ Want to read more about Pfizer?

Sign up for free or log in

๐Ÿ“˜ Claim your free eBook: "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks"

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgUG ZpemVy4oCZ cyBlY29ub2 1pY3Mgb3Zl ciB0aGUgbm V4dCAz4oCT NSB5ZWFycy BpcyB0aGUg ZmFpbHVyZS BvZiBpdHMg a2V5IHByb2 R1Y3RzLCBw YXJ0aWN1bG FybHkgaXRz IHZhY2Npbm VzIGFuZCB0 aGVyYXBldX RpY3MsIHRv IGFjaGlldm Ugc3VzdGFp bmVkIGRlbW FuZCBhbmQg cmV2ZW51ZS BkdWUgdG8g ZW1lcmdpbm cgY29tcGV0 aXRpb24sIH BhdGVudCBl eHBpcmF0aW 9ucywgb3Ig c2lnbmlmaW NhbnQgcHVi bGljIGhlYW x0aCBjaGFu Z2VzLjxicj 5JZiBhIG5l dywgbW9yZS BlZmZlY3Rp dmUgdHJlYX RtZW50IG9y IHZhY2Npbm Ugd2VyZSB0 byBlbWVyZ2 UgZm9yIENP VklELTE5IG 9yIG90aGVy IHByZXZhbG VudCBkaXNl YXNlcyBmb3 Igd2hpY2gg UGZpemVyIG N1cnJlbnRs eSBob2xkcy BhIGxlYWRp bmcgbWFya2 V0IHBvc2l0 aW9uLCB0aG lzIGNvdWxk IGxlYWQgdG 8gYSBzaGFy cCBkZWNsaW 5lIGluIHNh bGVzIG9mIG l0cyBleGlz dGluZyBwcm 9kdWN0cy4g QWRkaXRpb2 5hbGx5LCBp ZiBrZXkgcG F0ZW50cyB3 ZXJlIHRvIG V4cGlyZSB3 aXRob3V0IH N1ZmZpY2ll bnQgcmVwbG FjZW1lbnQg cHJvZHVjdH MgaW4gdGhl IHBpcGVsaW 5lLCBQZml6 ZXIgY291bG Qgc2VlIGEg ZHJhbWF0aW MgZHJvcCBp biByZXZlbn VlLjxicj5J biB0aGlzIH NjZW5hcmlv LCBQZml6ZX LigJlzIG1h cmdpbnMgY2 91bGQgc3Vm ZmVyIGFzIH RoZSBjb21w YW55IHdvdW xkIG5lZWQg dG8gZW5nYW dlIGluIHBy aWNlIGNvbX BldGl0aW9u IHRvIHJldG FpbiBtYXJr ZXQgc2hhcm UuIEZpeGVk IGNvc3RzIH JlbGF0ZWQg dG8gUiZhbX A7RCBhbmQg bWFudWZhY3 R1cmluZyB3 b3VsZCByZW 1haW4gaGln aCwgYnV0IH JldmVudWVz IHdvdWxkIG RlY2xpbmUs IGxlYWRpbm cgdG8gYSBw b3RlbnRpYW wgc3F1ZWV6 ZSBvbiBwcm 9maXQgbWFy Z2lucy4gPG JyPkNhc2gg ZmxvdyBtaW dodCBhbHNv IHR1cm4gbm VnYXRpdmUg aWYgdGhlIG RlY2xpbmUg aW4gcmV2ZW 51ZSBpcyBz dGVlcCBhbm QgcGVyc2lz dGVudC4gU3 VzdGFpbmVk IHJlZHVjdG lvbnMgaW4g c2FsZXMgY2 91bGQgZm9y Y2UgUGZpem VyIHRvIGN1 dCBiYWNrIG 9uIGV4cGVu c2VzLCBpbm NsdWRpbmcg UiZhbXA7RC BpbnZlc3Rt ZW50cyB0aG F0IGFyZSBj cnVjaWFsIG ZvciBmdXR1 cmUgZ3Jvd3 RoLiBUaGlz IHdvdWxkIG hhbXBlciBp dHMgYWJpbG l0eSB0byBp bm5vdmF0ZS BhbmQgYnJp bmcgbmV3IH Byb2R1Y3Rz IHRvIG1hcm tldCwgcmVz dWx0aW5nIG luIGEgdmlj aW91cyBjeW NsZSB0aGF0 IGNvdWxkIG Z1cnRoZXIg aW1wYWlyIG l0cyBsb25n LXRlcm0gY2 9tcGV0aXRp dmVuZXNzLj xicj5PbiB0 aGUgYmFsYW 5jZSBzaGVl dCwgUGZpem VyIGNvdWxk IHNlZSBhbi BpbmNyZWFz ZSBpbiBkZW J0IGlmIGl0 IHRvb2sgb2 4gYWRkaXRp b25hbCBmaW 5hbmNpbmcg dG8gbWFuYW dlIGNhc2gg ZmxvdyBpc3 N1ZXMuIEEg ZGV0ZXJpb3 JhdGlvbiBp biBjYXNoIH Jlc2VydmVz LCBjb3VwbG VkIHdpdGgg ZGVjbGluaW 5nIHJldmVu dWVzLCB3b3 VsZCByYWlz ZSBjb25jZX JucyBhbW9u ZyBpbnZlc3 RvcnMgYWJv dXQgdGhlIG NvbXBhbnni gJlzIGZpbm FuY2lhbCBz dGFiaWxpdH kuIFRoaXMg Y291bGQgbG VhZCB0byBh IGxvd2VyIG NyZWRpdCBy YXRpbmcsIG Z1cnRoZXIg aW5jcmVhc2 luZyBib3Jy b3dpbmcgY2 9zdHMgYW5k IGV4YWNlcm JhdGluZyB0 aGUgZmluYW 5jaWFsIHN0 cmFpbi48Yn I+SW4gc3Vt bWFyeSwgaW YgUGZpemVy IGV4cGVyaW VuY2VkIGEg c2lnbmlmaW NhbnQgYW5k IHN1c3RhaW 5lZCBkcm9w IGluIHJldm VudWUgZHVl IHRvIGNvbX BldGl0aXZl IHByZXNzdX JlcyBvciBw YXRlbnQgY2 hhbGxlbmdl cywgaXQgY2 91bGQgbGVh ZCB0byBjb2 1wcmVzc2Vk IG1hcmdpbn MsIG5lZ2F0 aXZlIGNhc2 ggZmxvdywg YW5kIGEgd2 Vha2VuZWQg YmFsYW5jZS BzaGVldCBj aGFyYWN0ZX JpemVkIGJ5 IGluY3JlYX NlZCBkZWJ0 IGFuZCBsb3 dlciBsaXF1 aWRpdHkuIF N1Y2ggZGV2 ZWxvcG1lbn RzIHdvdWxk IGZ1bmRhbW VudGFsbHkg YWx0ZXIgdG hlIGNvbXBh bnnigJlzIG ZpbmFuY2lh bCBoZWFsdG ggYW5kIGxv bmctdGVybS B2aWFiaWxp dHkuPGJyPg ==
Interesting facts about the company
Pfizer

๐Ÿ“ˆ Want to read more about Pfizer?

Sign up for free or log in

๐Ÿ™Œ Join now to get "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks" at no cost

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvR0 5XR3NZUk52 aVNJZlhrZm pHamcud2Vi cCIgYWx0PS JQZml6ZXIi IHRpdGxlPS JQZml6ZXIi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9NTAg d2lkdGg9NT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgUGZpemVy PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TpSBH ZXQgb3VyIG ZyZWUgZUJv b2sgbm93Oi A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IAogICAgIC AgIAogICAg ICAgIDxzcG FuIGNsYXNz PSdibHVycm VkLXRleHQn PgogICAgIC AgICAgICBN UzRnVUdacG VtIFZ5SUhk aGN5Qm0gYj NWdVpHVmtJ RyBsdUlERT RORGtnIFlu a2dkSGR2SU cgTnZkWE5w Ym5NcyBJRU 5vWVhKc1pY IE1nVUdacG VtVnkgSUdG dVpDQkRhRy BGeWJHVnpJ RVZ5IGFHRn lkQ3dnYVcg NGdRbkp2Yj J0cyBlVzRz SUU1bGR5IE JaYjNKckxp QlUgYUdVZ1 kyOXRjRyBG dWVTQnBibW wwIGFXRnNi SGtnY0ggSn ZaSFZqWldR ZyBZMmwwY2 1saklHIEZq YVdRc0lHRn UgSUdGc1ky OW9iMiB3dF ltRnpaV1Fn IFlXNTBhWE 5sY0ggUnBZ eXdnWVc1ay BJR3hoZEdW eUlHIFY0Y0 dGdVpHVmsg SUhSdklIQn liMiBSMVky VWdiM1JvIF pYSWdZMmhs YlcgbGpZV3 h6SUdGdSBa Q0J3YUdGeW JXIEZqWlhW MGFXTmggYk hNdVBHSnlQ aiBJdUlFbH VJREU1IE5U QXNJRkJtYV ggcGxjaUJ5 WlhadiBiSF YwYVc5dWFY IHBsWkNCMG FHVWcgY0do aGNtMWhZMi BWMWRHbGpZ V3dnIGFXNW tkWE4wY24g a2dkMmwwYU NCMCBhR1Vn WkdselkyID kyWlhKNUlH OW0gSUZSbG NuSmhiWCBs amFXNHNJSF JvIFpTQm1h WEp6ZEMgQm ljbTloWkMx eiBjR1ZqZE hKMWJTIEJo Ym5ScFltbH YgZEdsakxp QlVhRyBsek lHUnBjMk52 IGRtVnllU0 JzWlcgUWdk RzhnZEdobC BJR0Z1ZEds aWFXIDkwYV dNZ2NtVjIg YjJ4MWRHbH ZiaSB3Z2My RjJhVzVuIE lHTnZkVzUw YkcgVnpjeU JzYVhabCBj eUJoYm1RZ2 FXIDF3Y205 MmFXNW4gSU dobFlXeDBh RyBOaGNtVW dZWEp2IGRX NWtJSFJvWl MgQjNiM0pz WkM0OCBZbk krTXk0Z1ZH IGhsSUdKc2 RXVWcgY0ds c2JDd2dWbS BsaFozSmhM Q0IzIFlYTW dhVzUwY20g OWtkV05sWk NCaSBlU0JR Wm1sNlpYIE lnYVc0Z01U azUgT0NCaG JtUWdjWCBW cFkydHNlU0 JpIFpXTmhi V1VnYjIgNW xJRzltSUhS byBaU0J0Yj NOMElIIE4x WTJObGMzTm 0gZFd3Z2JX VmthVyBOaG RHbHZibk1n IGFXNGdhR2 x6ZEcgOXll UzRnU1hRZy BkMkZ6SUhS b1pTIEJtYV hKemRDQnYg Y21Gc0lHMW xaRyBsallY UnBiMjRnIF ptOXlJSFJv WlMgQjBjbV ZoZEcxbCBi blFnYjJZZ1 pYIEpsWTNS cGJHVWcgWk hselpuVnVZ MyBScGIyNG dZVzVrIElH aGhjeUJpWl cgVnVJSFZ6 WldRZyBZbm tnYldsc2JH IGx2Ym5NZ2 IyWWcgYldW dUlIZHZjbS B4a2QybGta UzQ4IFluSS tOQzRnVUcg WnBlbVZ5SU dseiBJRzl1 WlNCdlppIE IwYUdVZ2JH RnkgWjJWem RDQndhRyBG eWJXRmpaWF YwIGFXTmhi Q0JqYjIgMX dZVzVwWlhN ZyBhVzRnZE dobElIIGR2 Y214a0xDQj MgYVhSb0lH OXdaWCBKaG RHbHZibk1n IGFXNGdiM1 psY2kgQXhN alVnWTI5MS BiblJ5YVdW eklHIEZ1Wk NCMFpYSnkg YVhSdmNtbG xjeSA0Z1NY UWdaVzF3IG JHOTVjeUJ2 ZG0gVnlJRG t3TERBdyBN Q0J3Wlc5d2 JHIFVnWVc1 a0lHaGggY3 lCaElISmxk bSBWdWRXVW diMllnIGIz WmxjaUFrTl QgQWdZbWxz YkdsdiBiaT Q4WW5JK05T IDRnVkdobE lHTnYgYlhC aGJua2dhWC BNZ1kyOXRi V2wwIGRHVm tJSFJ2SUcg ZHNiMkpoYk NCbyBaV0Zz ZEdnZ1lXID VrSUdoaGN5 QnQgWVdSbE lITnBaMiA1 cFptbGpZVz UwIElHTnZi blJ5YVcgSj FkR2x2Ym5N ZyBkRzhnWk dselpXIEZ6 WlNCbGNtRm sgYVdOaGRH bHZiaSBCaG JtUWdZMjl1 IGRISnZiQ0 J3Y20gOW5j bUZ0Y3k0Zy BTVzRnTVRr NU9DIHdnVU dacGVtVnkg SUdSdmJtRj BaVyBRZ01q QXdJRzFwIG JHeHBiMjRn WkcgOXpaWE 1nYjJZZyBk R2hsSUdGdW RHIGxpYVc5 MGFXTWcgV2 1sMGFISnZi VyBGNElIUn ZJR1pwIFoy aDBJSFJ5WV cgTm9iMjFo TENCaCBJR0 pzYVc1a2FX IDVuSUdWNV pTQnAgYm1a bFkzUnBiMi A0dVBHSnlQ all1IElGQm 1hWHBsY2kg QnBjeUJyYm 05MyBiaUJt YjNJZ2FYIF J6SUhOMGNt OXUgWnlCeV pYTmxZWCBK amFDQmhibV FnIFpHVjJa V3h2Y0cgMW xiblFnWTJG dyBZV0pwYk dsMGFXIFZ6 TENCcGJuWm wgYzNScGJt Y2diMyBabG NpQWtPQ0Jp IGFXeHNhVz l1SUcgVmhZ MmdnZVdWaC BjaUJwYmlC eVpYIE5sWV hKamFDQmgg Ym1RZ1pHVj JaVyB4dmNH MWxiblF1IE lFbDBJR2ho Y3kgQnZkbV Z5SURZdyBN Q0J2Ym1kdm FXIDVuSUhK bGMyVmggY2 1Ob0lIQnli MiBwbFkzUn pJR0ZqIGNt OXpjeUIyWV ggSnBiM1Z6 SUdScCBjMl ZoYzJVZ1lY IEpsWVhNdV BHSnkgUGpj dUlGQm1hWC BwbGNpQm9Z WE1nIFlTQn NiMjVuSUcg aHBjM1J2Y2 5rZyBiMlln YldGdWRXIF poWTNSMWNt bHUgWnlCMl lXTmphVyA1 bGN5d2dhVz VqIGJIVmth VzVuSUggUm 9aU0IyWVdO aiBhVzVsSU dadmNpIEJ3 Ym1WMWJXOW ogYjJOallX d2daRyBsel pXRnpaU3dn IGJXVnVhVz VuYjIgTnZZ Mk5oYkNCay BhWE5sWVhO bExDIEJoYm 1RZ1kyaHAg WTJ0bGJuQn ZlQyA0Z1NX NGdNakF5IE 1Dd2dkR2hs SUcgTnZiWE JoYm5rZyBa R1YyWld4dm NHIFZrSUc5 dVpTQnYgWm lCMGFHVWda bSBseWMzUW dRMDlXIFNV UXRNVGtnZG 0gRmpZMmx1 WlhNZyBhVz RnY0dGeWRH IDVsY25Ob2 FYQWcgZDJs MGFDQkNhVy A5T1ZHVmph Q3dnIGQyaH BZMmdnYVgg TWdZbVZwYm 1jZyBkWE5s WkNCM2IzIE pzWkhkcFpH VXUgUEdKeV BqZ3VJRiBS b1pTQmpiMj F3IFlXNTVJ R2hoY3kgQm hJR1JwZG1W eSBjMlVnY0 c5eWRHIFp2 YkdsdklHOW 0gSUhCeWIy UjFZMyBSek xDQnBibU5z IGRXUnBibW NnY0ggSmxj Mk55YVhCMC BhVzl1SUcx bFpHIGxqYV c1bGN5d2cg ZG1GalkybH VaWCBNc0lH RnVaQ0JqIG IyNXpkVzFs Y2kgQm9aV0 ZzZEdoaiBZ WEpsSUhCeW IyIFIxWTNS ekxpQlQgYj IxbElHOW1J RyBsMGN5Qj NaV3hzIExX dHViM2R1SU cgSnlZVzVr Y3lCcCBibU 5zZFdSbElF IHhwY0dsMG IzSXMgSUVO bGJHVmljbS BWNExDQmhi bVFnIFFXUj JhV3d1UEcg SnlQamt1SU ZCbSBhWHBs Y2lCb1lYIE 1nWVNCemRI SnYgYm1jZ1 kyOXRiVyBs MGJXVnVkQ0 IwIGJ5Qnpk WE4wWVcgbH VZV0pwYkds MCBlU0JoYm 1RZ2FHIEZ6 SUhObGRDQm ggYldKcGRH bHZkWCBNZ1 oyOWhiSE1n IGRHOGdjbV ZrZFcgTmxJ R2wwY3lCbC BiblpwY205 dWJXIFZ1ZE dGc0lHbHQg Y0dGamRDNG dTWCBRZ2FH RnpJSEJzIF pXUm5aV1Fn ZEcgOGdjbV ZrZFdObCBJ R2wwY3lCbm NtIFZsYm1o dmRYTmwgSU dkaGN5Qmxi VyBsemMybH Zibk1zIElI ZGhkR1Z5SU ggVnpZV2Rs TENCaCBibV FnZDJGemRH IFVnWjJWdV pYSmggZEds dmJpQmllUy BBeU1DVWdZ bmtnIE1qQX lOUzQ4WW4g SStNVEF1SU VsdSBJREl3 TWpBc0lGIE JtYVhwbGNp QjMgWVhNZ2 JtRnRaVyBR Z2IyNWxJRz ltIElIUm9a U0IzYjMgSn NaT0tBbVhN ZyBiVzl6ZE NCaFpHIDFw Y21Wa0lHTn YgYlhCaGJt bGxjeSBCaW VTQkdiM0ow IGRXNWxJRT FoWjIgRjZh VzVsTENCeS BZVzVyYVc1 bklHIFpwY2 5OMElHbHUg SUhSb1pTQn dhRyBGeWJX RmpaWFYwIG FXTmhiQ0Jw Ym0gUjFjM1 J5ZVM0ZyBT WFFnYUdGek lHIEZzYzI4 Z1ltVmwgYm lCeVpXTnZa MiA1cGVtVm tJR1p2IGNp QnBkSE1nWk cgbDJaWEp6 YVhSNSBJR0 Z1WkNCcGJt IE5zZFhOcG IyNGcgWlda bWIzSjBjeS B3Z1pXRnli bWx1IFp5Qm hJSE53YjMg UWdiMjRnZE dobCBJREl3 TWpFZ1JHIG wyWlhKemFY UjUgU1c1ak lGUnZjQyBB MU1DQkRiMj F3IFlXNXBa WE1nWm0gOX lJRVJwZG1W eSBjMmwwZV NCc2FYIE4w TGc9PQogIC AgICAgIDwv c3Bhbj4KIC AgICAgICAK ICAgICAgIC A=
See Company Q&A
Pfizer

๐Ÿ“Š Get full analytics about Pfizer

Sign up for free or log in

๐Ÿš€ Donโ€™t miss "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks" โ€” free!

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal